Instil Bio, Inc.
TIL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789769
No open-market purchases or sales by Instil Bio, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $29.2M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Instil Bio, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +3 vs. Q4 2024
- Shares held
- 5.25M
- +14.1K (+0.3%) vs. Q4 2024
- Total value
- $91.2M
- −$8.82M (−8.8%) vs. Q4 2024
- New holders
- 9
- 11 more added
- Sold out
- 6
- 12 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TIL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $29.2M |
| Q1 2026 | 32 | $34.6M |
| Q4 2025 | 29 | $48.9M |
| Q3 2025 | 34 | $81.3M |
| Q2 2025 | 38 | $96.9M |
| Q1 2025 | 43 | $91.2M |
| Q4 2024 | 40 | $100.0M |
| Q3 2024 | 49 | $358.0M |
| Q2 2024 | 30 | $43.5M |
| Q1 2024 | 31 | $45.9M |
| Q4 2023 | 30 | $30.0M |
| Q3 2023 | 58 | $34.3M |
| Q2 2023 | 62 | $45.3M |
| Q1 2023 | 73 | $60.9M |
| Q4 2022 | 79 | $64.1M |
| Q3 2022 | 95 | $577.0M |
| Q2 2022 | 99 | $550.9M |
| Q1 2022 | 79 | $1.27B |
| Q4 2021 | 77 | $1.99B |
| Q3 2021 | 64 | $1.28B |
| Q2 2021 | 62 | $1.35B |
| Q1 2021 | 56 | $1.62B |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Instil Bio, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 2 | $35 | 0.00% | −2,841−99.9% | Reduced |
| Frazier Financial Advisors, LLC | 15 | $261 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 34 | $590 | 0.00% | −9−20.9% | Reduced |
| Eq Wealth Advisors, LLC | 40 | $694 | 0.00% | +40 | New |
| Lindbrook Capital, LLC | 68 | $1.18K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 79 | $1.37K | 0.00% | +79 | New |
| Rhumbline Advisers | 114 | $1.98K | 0.00% | 00.0% | Unchanged |
| Bokf, NA | 454 | $7.88K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,392 | $24.2K | 0.00% | −18−1.3% | Reduced |
| BNP Paribas Arbitrage, SA | 3,232 | $56.1K | 0.00% | +156+5.1% | Added |
| Pinpoint Asset Management Ltd | 5,094 | $88.4K | 0.02% | +5,094 | New |
| Quest Partners LLC | 5,397 | $93.7K | 0.01% | +5,397 | New |
| Susquehanna International Group, LLP | 10,511 | $182.5K | 0.00% | +10,511 | New |
| Palo Alto Investors LP | 11,165 | $193.8K | 0.04% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 13,490 | $233.0K | 0.00% | +13,490 | New |
| Schonfeld Strategic Advisors LLC | 13,864 | $240.7K | 0.00% | +13,864 | New |
| Barclays PLC | 14,826 | $257.4K | 0.00% | +11,999+424.4% | Added |
| UBS Group AG | 17,280 | $300.0K | 0.00% | −73,806−81.0% | Reduced |
| State Street Corp | 17,595 | $305.4K | 0.00% | +2,800+18.9% | Added |
| Omers Administration Corp | 18,700 | $324.6K | 0.00% | +18,700 | New |
| Morgan Stanley | 19,351 | $335.9K | 0.00% | −16,690−46.3% | Reduced |
| Marshall Wace, LLP | 22,298 | $387.1K | 0.00% | −1,400−5.9% | Reduced |
| ADAR1 Capital Management, LLC | 24,328 | $422.3K | 0.08% | −7,380−23.3% | Reduced |
| Fred Alger Management, LLC | 31,314 | $543.6K | 0.00% | 00.0% | Unchanged |
| VR Adviser, LLC | 33,177 | $576.0K | 0.05% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 40,000 | $694.4K | 0.00% | −10,000−20.0% | Reduced |
| Geode Capital Management, LLC | 43,215 | $750.6K | 0.00% | +1,480+3.5% | Added |
| Assenagon Asset Management S.A. | 53,097 | $921.8K | 0.00% | −9,461−15.1% | Reduced |
| BlackRock, Inc. | 57,971 | $1.01M | 0.00% | −1,796−3.0% | Reduced |
| Velan Capital Investment Management LP | 69,000 | $1.20M | 1.23% | +69,000 | New |
| Dimensional Fund Advisors LP | 77,349 | $1.34M | 0.00% | +19,407+33.5% | Added |
| Boxer Capital Management, LLC | 80,125 | $1.39M | 0.42% | −275,375−77.5% | Reduced |
| Renaissance Technologies LLC | 104,943 | $1.82M | 0.00% | −28,812−21.5% | Reduced |
| OrbiMed Advisors LLC | 116,785 | $2.03M | 0.05% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 132,431 | $2.30M | 0.00% | +5,504+4.3% | Added |
| Vanguard Group Inc | 168,098 | $2.92M | 0.00% | +16,908+11.2% | Added |
| Siren, L.L.C. | 203,933 | $3.54M | 0.20% | +11,500+6.0% | Added |
| Millennium Management LLC | 212,244 | $3.68M | 0.00% | +158,991+298.6% | Added |
| Balyasny Asset Management LLC | 317,324 | $5.51M | 0.01% | +255,691+414.9% | Added |
| CPMG Inc | 410,922 | $7.13M | 43.55% | 00.0% | Unchanged |
| BML Capital Management, LLC | 416,720 | $7.23M | 5.85% | +16,720+4.2% | Added |
| Vivo Capital, LLC | 585,485 | $10.2M | 1.35% | 00.0% | Unchanged |
| Curative Ventures V LLC | 1,899,004 | $33.0M | 100.00% | 00.0% | Unchanged |
| Superstring Capital Management LP | 0 | $0 | 0.00% | −148,017−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −34,557−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −12,533−100.0% | Sold out |
| Militia Capital Partners, LP | 0 | $0 | 0.00% | −416−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −113−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −20−100.0% | Sold out |